Site icon Fact.MR Blog

Flow Cytometry Sales Are Poised To Flourish At A CAGR Of 11.1% By The End Of 2032

download 2022 09 02T135037.250

A comprehensive estimate of the Flow Cytometry market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the Sales of Flow Cytometry during the forecast period. Price point comparison by region with the global average price is also considered in the study. This report works as a rich source of information for key entities such as policy makers, end-use industries, investors, and opinion leaders.

Click Here To get a Sample Report (Including Full TOC, Table & Figures):-https://www.factmr.com/connectus/sample?flag=S&rep_id=4633

Key Segments Covered

Competitive Landscape

Prominent Flow Cytometry providers are reliant on partnerships, collaborations, acquisitions, and new software launches so as to stay afloat in the global market. Constant innovations to ensure a seamless client-customer relationship are the main focus of prominent market players.

  • In April 2020, Merck, a leading science and technology company, launched its new CellStream™ benchtop flow cytometry system, a compact, customizable flow cytometer that uses a camera for detection. Its unique optics system and design provide researchers with unparalleled sensitivity and flexibility when analyzing cells and submicron particles.
  • In July 2021, Thermo Fisher Scientific Inc. TMO recently announced the launch of Thermo Scientific Phenom Pharos G2 Desktop Field Emission Gun — Scanning Electron Microscope (FEG-SEM). The instrument is designed to accelerate access to advanced nanomaterial research capabilities.
  • The Phenom Pharos G2 advances nanomaterial research by delivering high resolutions and a broad acceleration voltage range, all in a desktop system that can fit within a lab or office.
Exit mobile version